Health Care & Life Sciences » Pharmaceuticals | Ampio Pharmaceuticals Inc.

Ampio Pharmaceuticals Inc.

Ampio Pharmaceuticals Inc.
Stock Exchange NYSE
EPS
$0.07
Market Cap
$60.79 M
Shares Outstanding
141.38 M
Public Float
86.6 M

Profile

Address
373 Inverness Parkway
Englewood Colorado 80112
United States
Employees -
Website http://www.ampiopharma.com
Updated 07/08/2019
Ampio Pharmaceuticals, Inc. is a biopharmaceutical company, that engages in the development of therapies to treat prevalent inflammatory conditions. Its product pipeline includes new uses for approved drugs and new molecular entities for important therapeutic areas, including metabolic disease, eye disease, kidney disease, inflammation, sexual dysfunction and CNS disease. The company was founded by David Bar-Or in April 2010 and is headquartered in Greenwood Village, CO.

Financials

View All
Created with Highcharts 5.0.14Ampio Pharmaceuticals Inc.Net Income. Fiscal year is January-December. All values USD Thousands.24 00824 00838 12538 12522 40422 40419 16319 16351 89151 89133 98633 986201320142015201620172018010k20k30k40k50k60k
Created with Highcharts 5.0.14Ampio Pharmaceuticals Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.505076760000001 2811 2812013201420152016201720180250500750100012501500

Michael Macaluso
Chairman & Chief Executive Officer
David Bar-Or
Director & Chief Scientific Officer